Dyslipidemias
Dyslipidemias(血脂异常)
Dyslipidemias 相关产品(102)
- GC19831SCD1 inhibitor-4CAS: 1295541-87-5纯度: >98.50%
SCD1 inhibitor-4 是一种有效的、具有口服活性的硬脂酰辅酶A 去饱和酶-1 (SCD1) 抑制剂。
- GC20027(±)5(6)-DiHET MaxSpec® StandardCAS: 213382-49-1纯度: >95.00%
5(6)-DiHET is a fully racemic version of the enantiomeric forms biosynthesized from 5(6)-EET by epoxide hydrolases.
- GC26431Pentacosafluorotridecanoic AcidCAS: 72629-94-8纯度: >97.00%
Perfluorotridecanoic Acid (Perfluorinated Compound (PFC)) is a perfluorinated alkyl acid (PFAA) and a possible organic pollutant.
- GC40094all-trans Retinoic Acid-d5纯度: >99.00%
An internal standard for the quantification of all-trans retinoic acid
- GC40203Cholesterol-d6CAS: 60816-17-3纯度: >99.00%
An internal standard for the quantification of cholesterol
- GC40220Pravastatin-d3 (sodium salt)CAS: 1329836-90-9纯度: >99.00%
An internal standard for the quantification of pravastatin
- GC40228Fluvastatin-d6 (sodium salt)纯度: >95.00%
An internal standard for the quantification of fluvastatin
- GC40954(±)-N-3-BenzylnirvanolCAS: 93879-40-4纯度: >98.00%
A racemic mixture of (+)-N-3-benzylnirvanol and (–)-N-3-benzylnirvanol
- GC43646Ezetimibe Hydroxy GlucuronideCAS: 536709-33-8纯度: >95.00%
A minor phase II metabolite of ezetimibe
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC18205 | 3,5-Diiodothyroacetic Acid | 1155-40-4 | >98.00% | |
A thyroid hormone derivative | ||||
| GC18270 | 22(S)-hydroxy Cholesterol | 22348-64-7 | >95.00% | |
A synthetic oxysterol and LXR modulator | ||||
| GC18762 | Remogliflozin A | 329045-45-6 | - | |
A potent inhibitor of SGLT2 | ||||
| GC19824 | (±)-Pinocembrin | 68745-38-0 | >98.00% | |
A flavonoid with diverse biological activities | ||||
| GC19831 | SCD1 inhibitor-4 | 1295541-87-5 | >98.50% | |
SCD1 inhibitor-4 是一种有效的、具有口服活性的硬脂酰辅酶A 去饱和酶-1 (SCD1) 抑制剂。 | ||||
| GC19910 | 2,2',4,4'-Tetrabromodiphenyl Ether | 5436-43-1 | >95.00% | |
| GC20027 | (±)5(6)-DiHET MaxSpec® Standard | 213382-49-1 | >95.00% | |
5(6)-DiHET is a fully racemic version of the enantiomeric forms biosynthesized from 5(6)-EET by epoxide hydrolases. | ||||
| GC20142 | Beta-Sitosterol | 83-46-5 | >98.00% | |
Beta-Sitosterol是一种具有多种生物活性的植物甾醇，具有抗炎、抗肿瘤、退热和免疫调节等活性。 | ||||
| GC26431 | Pentacosafluorotridecanoic Acid | 72629-94-8 | >97.00% | |
Perfluorotridecanoic Acid (Perfluorinated Compound (PFC)) is a perfluorinated alkyl acid (PFAA) and a possible organic pollutant. | ||||
| GC40024 | Altenusin | 31186-12-6 | >98.00% | |
A fungal metabolite with diverse biological activities | ||||
| GC40094 | all-trans Retinoic Acid-d5 | - | >99.00% | |
An internal standard for the quantification of all-trans retinoic acid | ||||
| GC40167 | 1,3-Dipalmitoyl-2-Docosahexaenoyl-rac-glycerol | 214038-32-1 | >98.00% | |
A triacylglycerol | ||||
| GC40203 | Cholesterol-d6 | 60816-17-3 | >99.00% | |
An internal standard for the quantification of cholesterol | ||||
| GC40220 | Pravastatin-d3 (sodium salt) | 1329836-90-9 | >99.00% | |
An internal standard for the quantification of pravastatin | ||||
| GC40228 | Fluvastatin-d6 (sodium salt) | - | >95.00% | |
An internal standard for the quantification of fluvastatin | ||||
| GC40636 | Amorfrutin A | 80489-90-3 | >97.00% | |
An antidiabetic natural product | ||||
| GC40954 | (±)-N-3-Benzylnirvanol | 93879-40-4 | >98.00% | |
A racemic mixture of (+)-N-3-benzylnirvanol and (–)-N-3-benzylnirvanol | ||||
| GC41339 | Pioglitazone Ketone | 146062-45-5 | >98.00% | |
An active metabolite of pioglitazone | ||||
| GC41846 | 1,3-Dioctanoyl-2-Oleoyl-rac-glycerol | 109796-58-9 | >98.00% | |
A triacylglycerol | ||||
| GC41850 | 1,3-Dipalmitoyl-2-Eicosapentaenoyl-rac-glycerol | 148691-18-3 | >98.00% | |
A triacylglycerol | ||||
| GC42791 | Amorfrutin B | 78916-42-4 | >97.00% | |
A PPARγ agonist | ||||
| GC43136 | Campestanol | 474-60-2 | >98.00% | |
A phytosterol | ||||
| GC43646 | Ezetimibe Hydroxy Glucuronide | 536709-33-8 | >95.00% | |
A minor phase II metabolite of ezetimibe | ||||
| GC43764 | GLP-2 (human) (trifluoroacetate salt) | - | >95.00% | |
A peptide hormone | ||||